Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Govindan Subramanian

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Computational Chemistry|June 26, 2024
Monovalent cation binding to model systems and the macrocyclic depsipeptide, emodepsideGovindan Subramanian, Kanika Manchanda, Yirong Mo, et al.
Journal of Computer-Aided Molecular Design|June 1, 2010
Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1Supriyo Bhattacharya, Govindan Subramanian, Spencer Hall, et al.
Progress in Medicinal Chemistry|January 9, 2003
Molecular modeling of opioid receptor-ligand complexesIain McFadyen, Thomas Metzger, Govindan Subramanian, et al.
Angewandte Chemie (International Ed. in English)|February 8, 2003
A diboracyclopropane with a planar-tetracoordinate carbon atom and a triborabicyclobutaneYüksel Sahin, Carsten Präsang, Matthias Hofmann, et al.
Organic & Biomolecular Chemistry|September 9, 2020
Connecting the conformational behavior of cyclic octadepsipeptides with their ionophoric property and membrane permeabilityThomas Stadelmann, Govindan Subramanian, Sanjay Menon, et al.
RSC Medicinal Chemistry|January 22, 2021
Synthetic inhibitor leads of human tropomyosin receptor kinase A (<i>h</i>TrkA)Govindan Subramanian, Rajendran Vairagoundar, Scott J Bowen, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2019
Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA)Govindan Subramanian, Scott J Bowen, Yaqi Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2019
Lead identification and characterization of hTrkA type 2 inhibitorsGovindan Subramanian, Yaqi Zhu, Scott J Bowen, et al.
ACS Chemical Biology|May 7, 2019
Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A ( hTrkA) InhibitorsGovindan Subramanian, Paul D Johnson, Theresa Zachary, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
In Pursuit of an Allosteric Human Tropomyosin Kinase A (<i>h</i>TrkA) Inhibitor for Chronic PainGovindan Subramanian, Brian Duclos, Paul D Johnson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Computational Chemistry|June 26, 2024
Monovalent cation binding to model systems and the macrocyclic depsipeptide, emodepsideGovindan Subramanian, Kanika Manchanda, Yirong Mo, et al.
Journal of Computer-Aided Molecular Design|June 1, 2010
Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1Supriyo Bhattacharya, Govindan Subramanian, Spencer Hall, et al.
Progress in Medicinal Chemistry|January 9, 2003
Molecular modeling of opioid receptor-ligand complexesIain McFadyen, Thomas Metzger, Govindan Subramanian, et al.
Angewandte Chemie (International Ed. in English)|February 8, 2003
A diboracyclopropane with a planar-tetracoordinate carbon atom and a triborabicyclobutaneYüksel Sahin, Carsten Präsang, Matthias Hofmann, et al.
Organic & Biomolecular Chemistry|September 9, 2020
Connecting the conformational behavior of cyclic octadepsipeptides with their ionophoric property and membrane permeabilityThomas Stadelmann, Govindan Subramanian, Sanjay Menon, et al.
RSC Medicinal Chemistry|January 22, 2021
Synthetic inhibitor leads of human tropomyosin receptor kinase A (<i>h</i>TrkA)Govindan Subramanian, Rajendran Vairagoundar, Scott J Bowen, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2019
Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA)Govindan Subramanian, Scott J Bowen, Yaqi Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2019
Lead identification and characterization of hTrkA type 2 inhibitorsGovindan Subramanian, Yaqi Zhu, Scott J Bowen, et al.
ACS Chemical Biology|May 7, 2019
Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A ( hTrkA) InhibitorsGovindan Subramanian, Paul D Johnson, Theresa Zachary, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
In Pursuit of an Allosteric Human Tropomyosin Kinase A (<i>h</i>TrkA) Inhibitor for Chronic PainGovindan Subramanian, Brian Duclos, Paul D Johnson, et al.
Pageof 3